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ABSTRACT 
 
Background 
Cervical cancer is one of the common cancers worldwide. Despite the available 
screening services, the uptake of cancer of the cervix is very low. The incidence and 
mortality in western countries has reduced greatly due to the introduction of cervical 
cancer screening programmes. However, this is not the same in Africa where cervical 
cancer is more prevalent in lower resource countries to lack of access to effective 
screening and services that enhances early detection and treatment. 
 
Purpose/Aim of the study 
The purpose of this research is to determine knowledge of cervical cancer and the level 
of awareness of screening regimes/routines among HIV positive women in Swaziland. 
The study was conducted at one hospital specifically at the HIV Care Unit and Public 
Health Unit between January and June 2015. 
 
Methods 
The questionnaire was administered to collect data and consisted both open and close-
ended questions. The questionnaire comprises of three sections: Section A: Socio-
demographic data and Section B: Awareness on Cervical Cancer. Section C: 
Awareness/knowledge on cervical cancer screening. The sample consisted of 123 HIV 
positive who are on antiretroviral therapy (ART) or ART naive. The mean age for the 
respondents was 35 years. 
 
Results 
From this study, N=28 (23%) out of 123 (77%) reported to have received annual Pap 
smear for cervical cancer screening. A low proportion of the respondents (45%) had 
knowledge on cervical cancer screening. In addition, 63% of those who got information 
about cervical cancer screening through the radio perceived themselves to be at risk of 
getting cervical cancer. Only 4% heard about cervical cancer at the ART clinic, despite 
having been followed up for their care at the HIV clinic. Those who screened for cervical 
cancer were younger in age 25-34 years (80%). This study also revealed that education 
increased the changes of a woman to be screened for cervical cancer. If a woman had 
a university or high school education, she perceived herself to be at risk of getting 
cervical cancer. 
 
Conclusion 
Knowledge is power, cervical cancer campaigns should be conducted at national level 
in order to promote prevention through screening. Cervical cancer screening should be 
fully integrated into HIV services. 
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CHAPTER 1 
 
ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION 
Globally, cervical cancer is an avoidable cause of death among women in the sub-
Saharan Africa with a total of 528 000 new cases every year It is the most common 
cancer affecting women worldwide (South African Litigation centre 2012:7). WHO 
(2014:4) reported that in the year 2012, 528 000 new cases of cervical cancer were 
diagnosed, and 266 000 women died of the disease, nearly 90% of them in low- to 
middle-income countries. About 70% of cervical cancer global burden occurs in areas 
will low levels of development and more than a fifth of the cases are from India 
(Sankaranarayanan, Kumar & Budukh 2011:954).  
 
The World Health Organisation 2006 states that in sub-Saharan Africa, 34.8 new cases 
of cervical cancer are diagnosed per 100 000 women annually, and 22.5 per 100 000 
die due to cervical cancer. In contrast, in North America, there is a lower incidence of 
6.6 and 2.5 per 100 000. Therefore, the higher incidence in sub-Saharan Africa can be 
attributed to lack of access to effective screening and services that enhances early 
detection and treatment. 
 
According to Globocan 2012: 12, an estimated 14.1 million new cases of cervical cancer 
and 8.2 million cancer-related deaths occurred in 2012, while 12.7 million and 7.6 
million respectively occurred in 2008. According to estimates for 2012, the prevalence of 
cervical cancer was 32.6 million who were alive and diagnosed. All of the cases were 
above 18 years of age. 
 
It is postulated by Parkin, Bray and Devesa (2011:6) that cervical cancer is an avoidable 
cause of death among women in the sub-Saharan Africa, the region is still having a total 
of 528 000 new cases every year. It is the most common cancer affecting women 
worldwide. Cervical cancer is most prevalent in lower resource countries. 
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The above statistics show that there is need to implement mechanisms for preventing 
cervical cancer, namely, HPV and national screening programmes and treatment (IARC 
2012).  
 
Moodley 2009:13 refers to cancer of the cervix as a serious burden on the reproductive 
health of women world-wide despite the fact that it is preventable. According to the 
WHO 2009; there were about 5000 000 new cases and more than 250 000 deaths 
among women that were recorded as a result of this preventable disease. It is 
emphasised that early screening is a proven cost-effective cervical cancer control 
strategy (Blair & Casas 2009:36). 
 
The political and programmatic linking of sexual and reproductive health and Human 
Immunodeficiency Virus (HIV) responses has been gaining momentum. This linking has 
been implemented due to the fact that the majority of HIV infections are sexually 
transmitted. Sexual and reproductive ill-health and HIV share root causes like economic 
inequality, limited access to appropriate information, gender inequality, harmful cultural 
norms and social marginalization of the most vulnerable populations (UNAIDS 2010:4). 
 
The trend of cervical cancer being most prevalent among women in low resource 
settings is not unique to Africa. It is also seen in other developing parts of the world 
(Haiti 93 per 100 000; Zimbabwe 52 per 100 000; Malawi 56 per 100 100; Swaziland 52 
per 100 100). In contrast, very low rates are seen in developed countries. Cancer of the 
cervix develops in the tissues of the cervix. It is usually a slow-growing cancer that may 
not have symptoms but can be detected with regular Pap tests. In addition, cancer of 
the cervix is almost caused by Human Papilloma Virus (HPV) infection. Cervical cancer 
is malignant neoplasm of the cervix uteri or cervical area. It can manifest itself with 
vaginal bleeding and symptoms may not be present until at an advanced stage 
(WHO/ICO Information Centre on HPV and Cervical Cancer 2009). Treatment of 
cervical cancer consists of surgery (including local excision) in early stages, and then 
chemotherapy and radiotherapy in the advanced stages. Pap smear screening can 
identify potentially precancerous changes. The development of cancer can be 
prevented by the treatment of high grade changes. 
 
In 1993, cervical cancer was classified as an AIDS defining illness by the Centres for 
Disease Control (CDC). AIDS is caused by HIV infection, which is another public health 
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concern. Sub-Saharan region is also greatly affected by the HIV epidemic and accounts 
for 69% of the 34 million people living with HIV in the world, with 26% of them being for 
the reproductive age group (15-49) years while women are the most affected population 
group who constitute 58%. 
 
HIV situation in Swaziland  
 
Due to the high prevalence in Swaziland, it is very critical to assess the 
awareness/knowledge of cervical cancer amongst HIV positive women (Swaziland HIIV 
Incidence Measurement Survey 2012:21). As indicated by (Shims 2012: 2), that the 
overall prevalence of HIV among men and women aged 18-49 is 31%. Prevalence is 
higher in women (38%) compared to men (23%). In both men and women, HIV rises 
steeply from the youngest age groups, and peaks before the age of 40. Lastly, the HIV 
prevalence peaked at 54% among women. 
 
According to the Swaziland Integrated HIV Management Guidelines 2014:63, the 
country has incorporated in the national ART guidelines a section focusing on cervical 
cancer screening. The available screening tests include cytology which is the 
conventional Pap smear and VIA. This is the method that is widely used in the country. 
There are also management options for clients with pre-cancer lesions. Here biopsy is 
performed with the aid of coloscopy in order to support the HIV positive as several 
studies have revealed that HIV positive women are more vulnerable to getting cervical 
cancer than their HIV negative counterparts. On the other hand, patients need to be well 
informed about cervical cancer. This enables them to take informed decision on cancer 
prevention and management. Knowledge about cervical cancer screening promotes 
women to screen for it, thus preventing its occurrence. This study will give an insight on 
the knowledge and awareness of women about cervical cancer screening. The factors 
affecting women to screen or not to screen will be explored. This will help in the 
prevention of morbidity and mortality of women. The study will also assist in future 
programming for better sexual and reproductive health issues. 
 
1.2 BACKGROUND TO THE RESEARCH PROBLEM 
 
According to Ayinde, Omigbodun and Ilesanm (2004:69), epidemiological studies are 
coupled with recent advanced molecular biology coupled with recent advanced biology. 
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Findings have established a strong causal association between infection by certain 
serotypes (particularly 16 and 18) of sexually transmitted Human Papilloma Virus (HPV) 
and cervical cancer. An important factor is that the HPV link works by triggering 
alterations in the cells of the cervix which can lead to the development of the cervix 
intra-epithelial neoplasia, which will result in cancer. 
 
In Swaziland, cervical cancer is the leading cancer among women aged 15–44 years 
where approximately 198 women are diagnosed with cervical cancer annually, of which 
110 die of the disease (Human Papilloma Virus and Related Cancers, fact sheet 2013: 
January 3,2014). HIV is one of the risk factors for cervical cancer. Therefore, this calls 
for intervention in the country. In Swaziland, there is late detection of the disease Even 
if treatment is started, the likelihood of success is reduced and many cases remain 
undiagnosed. Balogun, Odukoya, Oyedivan and Ujomu (2012:76) argue that the most 
important risk factor in developing countries is infrequent cervical screening services 
and lack of effective cytological screening programmes. Although there is overwhelming 
evidence that cervical cancer today is almost totally preventable to a large extent 
through screening and treatment of pre-malignant lesions, the service is unfortunately 
not readily available to the general population. This is prevalent especially in developing 
countries such as Swaziland. Due to late detection of the disease, even if the treatment 
is started, the likelihood of success is reduced. 
 
1.3 STATEMENT OF THE RESEARCH PROBLEM 
 
Cervical cancer is one of the non-communicable diseases affecting women. It is the 
second most common cancer in women worldwide. Prevention of cervical cancer relies 
on the detection and treatment of squamous intraepithelial lesion, which is a 
premalignant stage. 
 
There is also a low uptake of women screening for cancer of the cervix; and women in 
Swaziland also come late for the screening. Moreover, there is paucity of data in 
relation to high HIV infection and high rate of cancer of the cervix, and maybe due to the 
fact that Swaziland does not have a comprehensive service on management of cancer 
of the cervix. To the researcher’s knowledge there has not been a study conducted to 
assess the level of awareness / knowledge about cervical cancer screening among HIV 
positive women in Swaziland. 
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1.4 RESEARCH AIM/PURPOSE 
 
The purpose of this research is to develop a suitable health education strategy to 
educate the community on the importance of early seeking of cervical screening for HIV 
positive women in Swaziland. 
 
1.4.1 Research objectives 
 
To meet the purpose of the study, the following objectives were formulated:  
 
 To identify and characterize socio-economic factors associated with accessing 
cervical cancer screening services by women in Swaziland. 
 To explore the factors affecting the uptake of cervical screening for cancer of 
women in Swaziland. 
 To assess knowledge of cervical cancer and awareness of screening 
regimes/routines among HIV positive women in Swaziland. 
1.5 RESEARCH QUESTIONS  
 
This study seeks to answer the following research questions: 
 
 What are the socio-economic demographic factors associated with accessing 
cervical cancer screening services by women in Swaziland? 
 What are factors affecting the uptake of cervical screening for cancer of women 
in Swaziland? 
 What is the level of awareness and knowledge about cervical cancer among 
women in Swaziland? 
 
1.6 DEFINITIONS OF KEY CONCEPTS 
 
For the purpose of this study the following terms are defined and further explained: 
 
Awareness 
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Awareness is the state or ability to perceive, to feel, or to be conscious of events, 
objects, thoughts, emotions or sensory pattern (Oxford Concise English Dictionary 
2003). Knowledge or understanding of a particular subject or situation: environment or 
political (Dictionary of Contemporary English 2006:88). 
 
A risk factor is any attribute, characteristic or exposure of an individual that increases 
the likelihood of developing a disease or injury, for example, Smoking is a risk factor for 
lung cancer (Oxford Concise English Dictionary 2003:88). 
 
Cervix 
 
This is the inferior bottom part of the uterus that is located in the vagina (Smeltzer & 
Bare 2012:1396).
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Cervical cancer 
 
Cancer of the cervix is most often asymptomatic. When discharge, irregular bleeding, or 
pain, or pain or bleeding after sexual intercourse occurs, the disease maybe advanced. 
Vaginal discharge gradually increases in amount and finally is dark and foul smelling 
because of necrosis and infection of the tumour (Smeltzer & Bare 2012:147). 
 
Human Papilloma Virus 
 
The human papilloma virus is a viral infection of the reproductive tract. Sexually active 
men and women will be infected at some point; reinfection also occurs many times. 
Skin-to-skin mode of transmission has also been identified (WHO 2012). 
 
1.7 RESEARCH METHODOLOGY 
 
1.7.1 Research design  
 
Research methodology refers to a scientific method that includes steps, procedures and 
strategies for obtaining and analysing data. It also provides answers to questions, and 
guidelines of dealing with difficulties arising during the research process that 
incorporates all procedures that scientists have used, and currently using, and could 
use in the future to search for knowledge (Burns & Grove 2005:23). The research 
methodology adopted for the study is quantitative, cross sectional and descriptive. 
These methods were used to assess the awareness and knowledge among HIV 
positive women about screening of cancer of the cervix. The quantitative method refers 
to the investigation of phenomena that lend themselves to precise measurement and 
quantification, often involving a rigorous and controlled design (Polit & Beck 2008:763). 
A cross-sectional study examines data at one point in time, meaning that data are 
collected on one occasion only for different subjects (Babbie 2010:106; Brink 2006:105; 
LoBiondo-Wood & Haber 2010:202). In this study, data will be collected once for every 
different study respondent. 
 
1.8 SETTING AND POPULATION OF THE STUDY 
 
Study setting 
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The study was carried out at a regional government hospital, which is also a regional 
referral hospital in Swaziland. The hospital has a separate clinic for care and treatment 
of HIV positive patients. 
 
Respondents were women enrolled in HIV care clinic in that regional hospital in 
Swaziland. The study population was HIV positive women above 18 years of age who 
are on anti-retroviral therapy (ART) or ART naïve who consented to participating in the 
study. The sample frame was obtained from the appointment register. 
 
1.8.1 Population and sample selection 
 
Respondents will be women enrolled into HIV care and treatment, who are on ART or 
ART naïve who consented to participate in the study. Respondents must be 18 years 
and above. Systematic random sampling was used whereby every third eligible woman 
at the ART clinic was selected for the study. Data collection was conducted from 08h00 
to 16h00 everyday through the data collection period. This method of sampling ensured 
that all patients seen throughout the period of data collection will have an equal 
probability of being sampled. 
 
Sample size 
 
For a precision of ±10% and a 95% Confidence Interval, the sample size needed works 
out to the following: 
 
 = 1.96* √ (p*q/n)  
0.12= 1.962*(p*q/n) 
n    = (1.96/0.1)2* (p*q) 
      = (2/0.1)2*(0.5*0.5) 
      ≈100 
Then for a response rate of 80% = 100/0.8 =125 
 
1.9 DATA COLLECTION METHODS AND PROCEDURES 
 
Data were collected over a period of 10 days through the use of interview administered 
questionnaire, and it contained both open and close-ended questions. The 
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questionnaire was in SiSwati and English. The principal investigator collected the data 
for accuracy. The questionnaire comprised three sections: Section A: socio-
demographic data; Section B: cervical screening uptake and Section C: 
Awareness/knowledge on cervical cancer screening. The local language version was 
then being pretested for ease of usage and comprehension. 
 
1.9.1 Reliability and validity 
 
The questionnaire was developed using the specific local language. The questionnaire 
was then back translated from the local language to English. A pilot test was conducted 
to establish the instrument’s reliability and validity, its format appropriateness, content 
validity, level of difficulty, and time of administration, as well as to verify data collection 
methods. Face and content validity of the questionnaire was tested with 10 patients who 
were not included in the main study. The test-retest method was used to establish 
reliability. The reliability co-efficiency of more than 0.70 was kept as it was and those 
below 0.70 were reworded.  
 
1.9.2 Data management and analysis 
 
The study was conducted between August 2014 and 2015 October. The data were 
collected at the selected hospital by the researcher using the questionnaire. The sample 
size for the study was 125. A database and entry screen were developed in Microsoft 
access 2013, of which the study dataset was mined and exported to Statistical Package 
for the Social Sciences (SPSS) version 22 for analysis. The objectives and questions of 
the study were used in developing a data analysis and tabulation plan to guide the 
analysis process. Descriptive analysis was accomplished by populating frequencies; 
tables and charts and cross tabulations for quantitative analysis. Post coding of 
quantitative data was conducted to analyse open-ended questions after which 
description of data in meaningful terms to obtain answers to research questions was 
conducted. 
 
1.10 ETHICAL CONSIDERATIONS 
 
The informed consent form information sheet was read by the researcher in a language 
they understood, and they signed or provided their thumb print if they indeed consent to 
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participating in the study. Respondents were encouraged to ask for clarity where 
needed. Respondents were encouraged to also ask questions, and each of these was 
addressed to them. Giving informed consent was entirely voluntary, and no coercion or 
duress was used. Furthermore, respondents were not compelled to remain in the study; 
they were free to withdraw at any time. 
 
To obtain approval to conduct the research at the hospital, the researcher wrote a 
formal letter to the Swaziland ethical clearance committee (Ministry of Health) (see the 
letter of request attached) (Annexure 1). 
 
Ethical clearance was also obtained from the Higher Degrees Committee of the 
Department of Health Studies, UNISA (Annexure 2). 
 
Permission to conduct the study was also requested from the Region through the 
regional health administrator (Annexure 3). The hospital received this same letter from 
the regional office to allow me to conduct the study. 
 
1.11 SIGNIFICANCE OF THE STUDY 
 
The findings of this study will assist the Swaziland Ministry of Health to recommend 
interventions aimed at increasing the uptake of cervical cancer screening and early 
identification of those at risk of developing cervical cancer, thereby reducing mortality 
and morbidity. In addition, the findings of the study shall be used to develop a suitable 
health education strategy to educate the community on the importance of early seeking 
of cervical screening. 
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1.12 SCOPE AND LIMITATIONS 
 
The study was done at one site in Swaziland and this will make it difficult to generalise 
the study findings beyond the study sample. 
 
1.13 CONCLUSION 
 
This chapter discussed the global picture of cervical cancer screening. It also provided 
an overview of the problem statement, the purpose and the objectives of the study, 
research questions as well as the significance of the study. A summary of the research 
methodology has also been described accordingly. A thorough review of the relevant 
literature review is presented in Chapter 2. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 INTRODUCTION 
 
In this chapter the literature as relevant to the topic of the study is discussed in detail. 
Firstly, the burden of cervical cancer worldwide will be discussed, then followed by 
review of research from the African continent and Swaziland in particular. 
 
According to Polit and Beck (2012:94), literature review is an essential summary of 
existing research on a topic of interest. It puts a study problem in context and it provides 
a basis for the implementation of a research project. Literature review also presents a 
foundation on which to base new knowledge. Burns and Grove (2005:95) state that the 
key purpose for reviewing relevant literature is to gain a broad background insight or 
understanding of the available information concerning a specific research problem. This 
foundation enables a researcher to build upon the findings of others, since major 
breakthroughs or discoveries of new information in a field are invariably based on 
previous work. 
 
From any given context, a description of a current knowledge can create an opportunity 
to debate and secure generally accepted facts and statements if they do give a true 
picture. Moreover, through detailed discussions given from literature studies, the 
researcher can identify gaps in what is known and indicates any statements with gap in 
knowledge as data could not be found during that period of researching. Against this 
background, this knowledge gap will persuade the current researcher to search for data. 
 
2.2 CERVICAL CANCER 
 
Cancer of the cervix is predominantly squamous cell cancer and also includes Adeno-
carcinomas. It is less common than it was because of early detection by the Pap test. 
Risk factors vary from multiple sex partners to smoking to cervical infection (exposure to 
human papilloma virus (HPV) (Smeltzer & Bare 2012:147). 
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Clinical manifestations 
 
In the early stages, cervical cancer does not have any symptoms. A very thin watery 
discharge maybe there but it maybe unnoticed. Usually, it occurs after sexual 
intercourse. A discharge, pain or bleeding after intercourse indicate that the disease is 
at an advanced stage. With this information, health care workers have a crucial role to 
educate clients on the causes, prevention and treatment of cervical cancer. 
 
At an advanced stage, the tissue outside the cervix maybe invaded. It has been 
observed that most of the time, the fundus is involved. Excruciating pain may occur as a 
result of affected nerves (Smeltzer & Bare 2010:1667). 
 
Clinical manifestation symptomatic 
 
Cervical cancer is most often asymptomatic. When there is irregular bleeding, pain or 
bleeding after sexual intercourse, the disease is at an advanced stage. With the 
advanced stage, leg pain, dysuria and rectal bleeding may occur. Emaciation and 
anaemia often with fever may follow due to secondary infection (Smeltzer & Bare 
2010:147). 
 
Stages of cervical cancer 
 
Cervical cancer is clinically staged; a doctor conducts a physical examination with other 
tests. The international Federation of Gynaecology and Obstetrics (FIGO) is the staging 
system used. This staging system classifies cervical cancer stages from I to IV as 
follows: 
 
 Stage I: Cancerous cells confined to the cervix only. 
 Stage II: Cancerous cells are now in other parts beyond the cervix. 
 Stage III: Signifies where the cancer is found either in the lower 3rd of the 
vagina, but not the pelvic wall. 
 Stage IV: Indicates cancerous cells that have spread from the cervix to the 
bladder, rectum or other areas of the body. 
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The impact of cervical cancer 
 
Worldwide, cervical cancer accounts for approximately 12.0% of all cancers in women. 
It is the second most common cancer in women worldwide, but the most common 
cancer among women in developing countries. It is estimated that over a million women 
worldwide currently have cervical cancer. Most of these women have not been 
diagnosed, nor do they have access to treatment that could cure them or prolong their 
lives. WHO (2014:4) reported that in the year 2012, 528 000 new cases of cervical 
cancer were diagnosed, and 266 000 women died of the disease, nearly 90% of them in 
low- to middle-income countries. Without urgent attention, deaths due to cervical cancer 
are projected to rise by almost 25% over the next 10 years (WHO 2014). At least 85.0% 
of cervical cancer deaths occur in developing countries with most occurring in the 
poorest regions which include, South Asia, sub-Saharan Africa (SSA) and parts of Latin 
America (WHO 2014). In SSA, cancer of the cervix is the leading cancer with an 
estimated 75 141 new cases in 2008, which is 14%of total world incident.  
 
The countries with highest rates include Zimbabwe, Uganda and Kenya. The disparity is 
attributed to the lack of effective screening programmes in developing countries that 
have a high incidence of cervical cancer (Mutyaba, Mmiro & Weiderpass 2006:15). 
Thus, cervical cancer has a devastating impact on women’s health around the world, 
particularly among women in the developing world. Invasive cervical cancer (ICC) is the 
most common cancer diagnosed in women in SSA, with 75 141 new cases reported per 
year, and also the leading cause of cancer death at 50 233 deaths annually. Rates of 
cervical cancer vary considerably indifferent sub-regions; Guinea, Zambia, Tanzania, 
Malawi, and Mozambique have some of the highest ICC incidence rates in the world at 
>50/100000 (Ferlay, Shin, Bray, Forman, Mathers & Parkin 2008:855). The writers 
note that the rate of cervical cancer in the United States of America (USA) between 
1947 and 1949, prior to the introduction of the Pap smear in the 1960s, was 40/100 000 
in white women and 73/100 000 in black women. These rates have considerably 
reduced. Within the SSA region, estimated age standardised incidence rates (ASIR) are 
the highest in Eastern and Western Africa with ASIR of 34.5 and 33.7 per 100 000 
women, respectively, and age standardised mortality rate (ASMR) of 25.3 and 24.0 per 
100 000 women, respectively. Not surprisingly, ICC is the most important cause for 
cancer death in women in Eastern, Western and Middle Africa and second most 
important cause after breast cancer in Southern Africa. The burden of ICC is highest in 
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Guinea, Zambia, Tanzania, Malawi and Mozambique with ASIRs greater than 50/100 
000 women and 25 per 100 000 in Kenya (De Vuyst, Alemany, Lacey, Chibwesha, 
Sahasrabuddhe, Banura Denny & Parham 2013:3). Cervical cancer is not a disease of 
old age, the majority of its victims are women who are at the peak of their biological and 
economically productive stages of life. This means, when a woman dies of cervical 
cancer, a life is not simply lost. Rather, a husband loses a wife, the children lose a 
mother, and the family is destabilised psychologically, financially and socially. At the 
same time, economically there is loss of a productive pair of hands and also a loss to 
the country which pays a large part of the cost of treating cervical cancer.  
 
2.2.1 Cervical cancer risk factors  
 
Cancer has different risk factors. Not all women exposed to the risk factors definitely 
develop cancer, but it is worth noting that the risk factors increase the odds of women 
getting it. Different risk factors of cervical cancer will be discussed. 
 
Aetiology of cervical cancer 
 
Cervical carcinoma is a condition that develops at the border of the cervix and the 
uterus. The major risk factor for the development of pre-invasive or invasive cervical 
carcinoma is infection with the HPV, which is transmitted sexually (Kimani et al 2012:9). 
The HPV can be detected in 99.7% of cervical cancers and is extremely common. Over 
50.0% of sexually active women acquire the virus by 50 years of age (Leslea, Donna, 
Donna & Rachel 2013:2046). Different types of HPV are identified as precursors to 
cervical cancer (Bain, Burton & Mcgavigan 2011:175). However, the two most common 
subtypes, HPV 16 and 18 are found in over 70.0% of all cervical cancers. The 
squamous epithelium cells found at this junction of the cervix and uterus divide rapidly 
and have the potential to undergo an abnormal transition to dysplastic cells, if exposed 
to carcinogens such as HPV 16 and 18 (Leslea et al 2013:2046). Cervical changes 
progress from mild to severe over a period of years before changing to cancer. This 
indicates that more than 90.0% of cervical changes can be detected early through 
regular screening and can be treated before progressing to malignancy (Denny, Kuhn, 
Hu &Tsai 2010:1566). Most HPV infections are transient. Only 3−10% of women whose 
infections are not cured becomes persistent HPV carriers, constituting a high risk group 
for progression to cancer of the cervix (Collymore 2008:3). He further (2008:3) adds that 
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women may contract HPV when they are young but only progress to cervical cancer 
once they become 35 years of age or older. Pre-cancerous stages of cervical dysplasia 
are frequently asymptomatic, emphasising the importance of screening for early 
detection. Risk factors for HPV include early age at first sexual intercourse, increased 
number of sexual partners, smoking, immune-suppression including the Human 
Immunodeficiency Virus (HIV), high parity, and low socio-economic status. Cervical 
Intraepithelial Neoplasia (CIN) is common in HIV infected women because both HIV and 
HPV are sexually transmitted and HIV infected women are more likely to have 
persistent HPV infections (Mutyaba et al 2006:13). According to Collymore (2008:2), 
global efforts to detect cervical cancer have focused on screening women for abnormal 
cervical tissues, treating the condition before it advances and providing appropriate 
follow-up care. In developed countries, there has been a 75.0% decrease in the 
incidence and mortality of cervical cancer over the past 50 years while in developing 
countries it remains the second most common cause of cancer-related morbidity and 
mortality. The discrepancy is largely due to the widespread institution of cervical cancer 
prevention and screening programmes in developed countries. Conversely, these 
programmes are essentially non-existent in most developing countries. A recent meta-
analysis of process of care failures in prevention of cervical cancer in developing 
countries revealed that poor screening history was the primary factor: 54.0% of invasive 
cervical cancer patients had inadequate screening histories and 42.0% had never been 
screened (Leslea et al 2013:2047). 
 
Available screening tests 
 
There are various types of cervical cancer screening tests available worldwide, included 
HPV/DNA, visual inspection with acetic acid (VIA), Pap smear and cervicography (Lee-
lin, Pett, Menon, Lee & Nail 2007:1204). Historically, visual inspection of the cervix with 
Lugol’s iodine, without magnification, was the initial method of screening of the cervix in 
the 1930s. This was rapidly replaced by cervical cytology because of its low sensitivity 
and specificity of 79.0% and 85.0% of VIA. As such, screening efforts have relied 
largely on Papanicolaou (Pap) smears to detect abnormal cell changes at the cervical 
transition zone (Denny et al 2010:1560). A Pap smear test became the standard for 
early detection of cervical cancer lesions from the 1950s (Sudenga et al 2013:897). Its 
sensitivity and specificity for CIN 2−3 is 70% to 80%, and 95% respectively. For 
developing countries, widespread utilisation of the Pap smear test presents a number of 
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challenges. These challenges have led to the re-introduction of VIA, which utilises the 
naked eye as a screening tool, for low resource settings. Despite its limited specificity, it 
is economical, requires little equipment, and provides immediate results (Denny et al 
2010:1561). Both the Pap smear and VIA screening are effective in detecting CIN grade 
2−3, which are considered to be true precancerous lesions (Gichangi, Estambale, 
Bwayo, Rogo, Ojwang & Opiyo 2003:828). The use of the HPV test, on its own or in 
combination with VIA, has the potential to improve cervical cancer screening in low 
resource settings. Unfortunately, it is expensive, requires infrastructure for processing, 
and has a long period of waiting for results. It has a higher sensitivity than VIA (90.2% 
vs. 41.4%), but a lower specificity (84.2% vs. 94.5%) (Sankaranarayanan 2009:1394). 
However, HPV testing is superior to VIA or cervical cytology because it detects a large 
number of high-risk sub-types of HPV. On the other hand, cervical cytology tests are 
excellent screening tools for pre-invasive cancer.  
 
This indicates that rapid results for HPV testing may be suitable for performing 
screening and treatment in low resource setting. Furthermore, the authors state that it is 
preferable to use a combination of two screening tests rather than either test alone to 
avoid missed diagnosis. In the Western world, a diagnosis of cervical cancer is often 
established by biopsy and pathology reports (Denny et al 2010:1561). Symptomatic 
women without a visible lesion and those who have only abnormal cervical cytology 
undergo colposcopy with directed biopsy. If necessary, this is followed by diagnostic 
conisation. A screening test, followed during the same visit by treatment of women with 
positive results, eliminates communication difficulties regarding results and issues of 
non-compliance with follow up clinic visits. Cryotherapy is the most cost effective and 
preferred treatment for a screen-positive VIA testing in developing countries. 
 
2.2.1.1 Human papilloma virus (HPV) 
 
HPV is mainly transmitted through sexual intercourse and this is the most important risk 
factor. HPV is not curable, but the lesions caused by its presence can be managed 
(American Cancer Society 2009: [1]). The HPV may cause a growth called papilloma 
which is most of the time referred to as warts. Warts are a common symptom of HPV, 
but the virus does not always produce symptoms among infected persons. An individual 
woman can have papilloma virus for many years and can transmit it to someone else 
without even knowing. HPV is common to women under the age of 30 years.  
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High risk types of HPV cause cervical cancer are types 16 and 18. They are both 
accountable for 70% of cervical cancer cases worldwide. There are vaccines that 
prevent these types of HPV and they can safely be administered with other vaccines 
like diphtheria, tetanus and pertussis (DPT) and hepatitis B. 
 
2.2.1.2 Cervical cancer and HIV/AIDS 
 
Swaziland is a small country located in Southern Africa. It is about 17,364 km2 and is 
landlocked with Mozambique in the East. Its neighbouring country is South Africa 
(Swaziland DHS 2007:42). 
 
Link between cervical cancer and HIV 
 
Cervical cancer was recognised as an AIDS-defining illness and as a leading cause of 
mortality in HIV-positive women by the US Centers for Disease Control and Prevention 
(CDC) in 1993:116. Although research into how specifically HIV affects the incidence of 
invasive cervical cancer is currently inconclusive and ongoing, there is no doubt that the 
negative effect of cervical cancer is exacerbated in southern Africa due in part to the 
high prevalence of HIV among women. 
 
Swaziland also has high HIV incidence rate of 2.9%, and the epidemic continues to 
grow unabatedly. Although the country is very small (1,167,834 people), the HIV 
population is estimated to be over 190 000. An estimated 1 in 3 women (the highest 
female prevalence in the world) are positive. Furthermore, the Swaziland HIV Incidence 
measurement survey results also indicate that HIV prevalence in men and women ages 
18-49 years is 31%. HIV and HPV have been associated with cervical cancer. The fact 
that Swaziland has a high HIV prevalence shows that cervical cancer rate will be high in 
the population. Therefore, screening becomes very relevant due to the HIV situation 
especially in women of child bearing age. 
 
A desktop research combined with field research study in Namibia and Zambia was 
conducted. It was supplemented with focused group discussions where respondents 
were women living with HIV. This study was done mainly to assess the availability and 
accessibility to cervical cancer services in the two countries. A total of 181 women from 
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both rural and urban areas were interviewed in 15 focused group discussions. The 
findings revealed that Namibia and Zambia have no policies in cervical cancer which 
contributed in low screening rates. Policies ensure that specific health services are 
implemented in a certain way. The absence of policies shows that there is no political 
will. However, Swaziland is a signatory to International and regional frameworks on 
sexual and reproductive health (SRH) committed to provide its citizens with 
comprehensive quality SRH services (Swaziland Cervical Guidelines 2013:1) Swaziland 
had its first guidelines on cervical cancer in 2013. 
 
In Swaziland, the national development strategy, the poverty reduction strategy and the 
national health policy support the provision of comprehensive quality SRH which 
includes the screening of cervical cancer and treatment. The study also revealed that 
level of awareness in the rural areas was low due to the fact that health care workers 
were misinforming their patients on the causes of cervical cancer. Different countries 
use different methods for the diagnosis of cervical cancer. In Zambia, the visual 
inspection method was used whereas Namibia uses Pap smear screening which 
creates barriers to access, partly due to the fact that health care workers do not screen 
patients for cervical cancer (Munazvo 2012:8). 
 
HIV-positive women are at increased risk for HPV infection and progression to cervical 
intraepithelial neoplasia grade 3 (CIN3) (De Vuyst, Lillo, Broutet & Smith 2008:32). 
Linkage studies between HIV/AIDS and cancer registries have shown a 2- to 22-fold 
increased invasive cervical carcinoma incidence in HIV-positive women compared with 
the general female population from the same area. However, this depends upon the life 
expectancy of HIV-positive women and the coverage and quality of cervical cancer 
screening in different countries (Srulich 2007:11). 
 
Other studies confirm the association between cervical cancer and HIV while other 
studies were not able to determine the association. Keller (2015:2) conducted a five-
year cohort study that looked at HIV positive and HIV negative women and concluded 
that cervical cancer incidence was the same regardless of HIV infection. 
 
In view of the previous studies, this study will be conducted in a place where HIV 
positive women receive their care and treatment. This study will assess whether 
  
20 
patients with HIV are aware of cervical cancer or not. Other factors affecting cervical 
cancer will also be considered/analysed to determine the association. 
 
2.2.1.3 Smoking 
 
Another risk of cervical cancer is smoking. Women who smoke are twice as likely as 
non-smokers to develop cervical cancer. This is because of the carcinogens in tobacco 
damaging the DNA of the cervical cancer cells, thus causing cervical cancer (American 
Cancer Society 2009:2). 
 
2.2.1.4 Other risk factors 
 
Cervical cancer can also be genetic. Women who have a family history of cervical 
cancer are 2-3 times more likely to develop cervical cancer than women without a 
history of cervical cancer. The use of contraceptives also predisposes an individual to 
cervical cancer, particularly the prolonged use of contraceptives 5-9 years (American 
Cancer Society 2009:4). Therefore, knowing and understanding the risk factors for 
cervical cancer is very important for early prevention and treatment 
 
2.3 CERVICAL CANCER PREVALENCE AND BURDEN 
 
Cervical cancer is the main cause of mortality in 40-80 countries of sub-Saharan 
countries. Cervical cancer is the most prevalent cancer among women (Global Burden 
of Disease 2013). VIA has been found to be an alternative for screening because it can 
be done by different health care workers. 
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2.3.1 The prevalence and burden of cervical cancer in Swaziland  
 
Swaziland has a population of 398 952 women who are aged 15 years and older who 
are at risk of developing cancer of the cervix. It is estimated that annually, there are 223 
women diagnosed of cervical cancer, of which 118 die from it. HPV burden data is not 
available in the general population (ICO HPV and related cancers, fact sheet 2014). 
 
In Swaziland, women of reproductive age are at high risk of cervical cancer due to the 
high prevalence of HIV and multiple sexual partners. The situation is further 
exacerbated by limited capacity for pathological diagnosis and effective treatment 
services (WHO Country Strategy 2008-2013:6). 
 
In Swaziland, cervical cancer is the leading sexual and reproductive health cancer (The 
Swaziland Cancer Guidelines 2013:4). Screening is offered in three hospitals, and they 
all screen and treat. All the public health units offer cervical cancer screening and refer 
suspicious results to the hospitals. Although the progression to cervical cancer can be 
stopped through early detection and treatment of precancerous changes, it still remains 
a major burden on public health resources in Swaziland (Sudenga et al 2013:895). 
Service challenges for cervical cancer screening and treatment are similar to those for 
other health interventions. They include: competing health needs, lack of political will, 
limited access to services, under developed health care structures, lack of knowledge 
about screening and treatment, limited financial, equipment, and human resources, 
costs, long queues and waiting times, missed referrals and follow-up. 
 
A descriptive study conducted in Swaziland by (Okondo 2009:14) revealed that very 
high rates of cytological abnormalities with 43.2% of smears screened were reported as 
abnormal. He also pointed out that the most cost effective combination of screening 
modalities such as visual inspection, HPV DNA testing and cytology should be 
investigated. He also concluded that cervical cancer reduction needs to be managed 
within the greater framework of the HIV/AIDS epidemic framework. 
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2.4 LITERATURE TO EVALUATE WOMEN’S KNOWLEDGE OF CERVICAL 
CANCER SCREENING REGIMENS/ROUTINES AMONG HIV POSITIVE 
WOMEN 
 
A descriptive study was conducted in rural KwaZulu-Natal, South Africa. The aim of the 
study is to access women’s awareness, attitudes and experiences regarding cervical 
smear testing and for cervical cancer screening. The study was also conducted to better 
understand the factors influencing access to and utilization of cervical cancer screening 
services by rural women. The author noted that out of 69 women, only N=13 (18.8%) 
reported ever screening for cervical cancer. More than half of women reported that lack 
of information resulted in them not to be screened for cervical cancer. It was observed 
that education influenced women positively to screen for cervical cancer. A total of 42 
(60.8%) of the respondents considered themselves to be at risk of getting cervical 
cancer and N=64 (93%) showed willingness to screen in the future (Ndlovu 2011:28). 
 
A study by Bingham (2009:12) showed lack of knowledge on relationship between HPV 
and cervical cancer among health care providers. The study conducted in four 
developing countries, namely; Peru, Uganda, Vietnam and India sought understanding 
of cancer, disease burden and aetiology of cervical cancer. The study population 
included health care workers, teachers, parents, students and civil society 
representatives and authorities. The knowledge and attitude of the health care workers 
directly affects the decision made by the people they interact with. This highlights the 
fact that knowledge alone cannot make women to screen for cervical cancer. 
 
A study was conducted at Ilorin, Nigeria on knowledge, attitude and practice of cervical 
smear as a screening procedure for cervical cancer. The respondents included nurses 
(83.9%), doctors (6.3%), medical laboratory technologies (4.8%) and pharmacists 
(2.5%). The findings of the study showed that 69.8% of the respondents knew Pap 
smear as a screening procedure for cervical cancer. Of these only 3% had Pap smear 
at least once previously the health care workers were significantly aware of the 
preventable nature of the cancers of the cervix but few were willing to utilize the service 
(Aboyeji et.al 2004:137). This study highlights the fact that knowledge alone does not 
allow people to utilise health services. This applies even to health workers as it is the 
case in this study. 
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In a rural KwaZulu-Natal, a study was conducted to determine baseline data regarding 
knowledge about risk factors for cervical cancer. The study showed a low uptake of the 
Pap smear test and a low level of knowledge on the prevention of cervical cancer risk 
factors and generally the uptake of the cervical cancer screening as a service. The 
study reported that only 6% had knowledge on all the risk factors while 65% knew only 
one of the risk factors of cervical cancer. Less than half (49%) of these patients stated 
correctly that the Pap smear screening test is used for early detection of cervical 
cancer; only 18% had ever been screened for cervical cancer (Hogue, Hogue & Kader 
2008:112). 
 
From the cases investigated, only 36.6% of women had consulted a gynaecologist 
(47.5%) among cases and 25.6% among controls and 3.9% had benefited from at least 
1 Pap smear screening. It was noted the average knowledge score was 3.5 on a 0-13 
scale, significantly higher in cases than controls. In this study, the women living with HIV 
had a better knowledge about cervical cancer despite the fact that their education and 
economic status was low. Health care professionals were the source of information. The 
reason why the cases did not undergo Pap smear was the absence of symptoms and 
default of medical injunction (Sichanh 2014:4). In this study, the controls showed lack of 
information on the usefulness of screening. The study showed that it is very important to 
inform women of their high risk to develop cervical cancer in HIV treatment centres. It 
also showed that it is not enough just to give information. Women need to know that 
they need to perform screening test and treat precancerous lesions before they 
advance. 
 
In 2013, a study was conducted on knowledge and attitude towards cervical cancer 
screening among female students and staff in tertiary institution in the Niger Delta. The 
study sought to assess the knowledge, level of perception and attitude of female staff 
and students of Niger Delta University in Nigeria towards cervical cancer screening. 
About 278 (72%) of the respondents were aware of cervical cancer, while 182 (50.6%) 
were aware of cervical cancer screening (Owoeye & Ibrahim 2013:51). The most 
screening method that was most common was the Pap smear 100 (41.2%). However, 
some respondents believed that the blood test is used for cervical cancer screening. In 
this study, there was an association between awareness and prevalence of cervical 
cancer screening among respondents. A greater proportion of the respondents had little 
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or completely no knowledge on cervical cancer screening. This implies that some 
women are not aware of cervical cancer. 
 
Another study was conducted to assess knowledge and awareness of cervical cancer 
and screening among Malaysian women who never had a Pap smear. The respondents 
showed lack of knowledge on cervical cancer and the Pap smear test. Respondents did 
not understand abnormal cervical cancer smear Thus; they did not see the reason why 
it is necessary for them to be screened so that any abnormalities could be screened. 
When respondents were asked about the risk factors, they were not aware of any; they 
never heard even of the papilloma-virus (Wong et.al 2009:4). The study revealed that 
accurate health education about cancer of the cervix is very important. 
 
A cross sectional descriptive study was conducted in five locations of Onisha. 
Respondents were taken from churches, business outlets, schools, banks and markets. 
The study was conducted to investigate the awareness of cervical cancer screening and 
uptake in Nigeria, South East among Onitsha women. About 450 questionnaires with 
closed-ended questions were used (Nwozor 2013:5). This study projects that if one is a 
professional or student, he/she is likely to be aware of cervical cancer. HIV affects 
anyone. The current study had respondents who are diverse in education and 
employment but they are expected to have some level of awareness in cervical cancer 
because they are prone to get it due to their decreased level of immunity. 
 
2.5 SUMMARY 
 
This chapter discussed the literature relevant to the global burden of cervical cancer, 
and revealed information on knowledge and awareness of cervical cancer. The 
literature review identified previous studies that have been done regarding this topic. 
 
Chapter 3 will discuss the research methodology to be used in this study. This will take 
account of the research design, setting, sampling data collection methods, data analysis 
processes and ethical considerations
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CHAPTER 3 
 
RESEARCH METHODOLOGY 
 
3.1 INTRODUCTION 
 
In Chapter 1, an overview of the study was described. The literature review in Chapter 2 
concentrated on the background of knowledge of cervical cancer and awareness of 
screening regimes/routines among HIV positive women. The chapter also critically 
analysed the research methodologies used in the reviewed studies, the findings, as well 
as some interventions done to improve cervical cancer awareness. 
 
In this chapter, the research methodological processes that were used in the current 
study are discussed. This includes the research design, study site, target population, 
sampling methods, data collection techniques, validity and reliability of the research 
instrument, pretesting of the research instrument, ethical considerations and data 
analysis procedures. 
 
3.2 RESEARCH DESIGN 
 
According to Polit and Beck (2008:203), the study design is the researcher’s general 
plan for responding to the research questions. Such a design includes an outline of 
what the investigator will do from the writing of the hypotheses, or research questions, 
and their operational implications to the final analysis of data. This research is hospital-
based quantitative, cross-sectional descriptive in nature. 
 
3.2.1 Quantitative descriptive study designs 
 
Polit and Beck (2008:249) point out that quantitative research is a formal, objective, 
systematic process in which numerical data are utilised to obtain information. The 
research technique was used to describe variables, examine relationships among 
variables, and determine cause effective interactions between variables. According to 
Burns and Grove (2005:23), quantitative research is considered to produce “a hard or 
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true” science that is based on rigour, objectivity and control. In addition, in quantitative 
descriptive research, investigators often employ different methods such as interviews, 
unstructured observations which are guided by checklist and questionnaires to identify 
and illustrate the trend being studied. Therefore, quantitative research utilises structured 
tools to generate numerical data and uses statistical methods to interpret, organise and 
present such collected data (Burns & Grove 2005:232). 
 
This study also described the existing cervical cancer screening regimens. According to 
Polit and Beck (2008: 274), a descriptive study design provides a way of discovering 
new meaning, describing what exists, determining the frequency with which a 
phenomenon occurs, and categorising information. It offers an accurate representation 
or account of characteristics of a particular individual, situation, or group (Burns & Grove 
2005:26; Polit & Beck 2008:274). 
 
3.3 RESEARCH SETTING 
 
The study site was selected by using a non-probability, purposive sampling technique. A 
research setting is the environment in which the study takes place. The setting can be 
natural or controlled (Burns & Grove 2005:346; Polit & Beck 2006:264; 2008:339). This 
study took place in a natural setting or real life environment and no manipulation or 
change of the environment had been made in the selected health facility which might 
have affected the findings of the study. 
 
3.4 POPULATION AND SAMPLE SELECTION 
 
According to Burns and Grove (2005:345) and Polit and Beck (2008: 339), sampling 
involves selecting a group of people, events, behaviours, or other elements with which 
to conduct a study. It is the process of selecting a number of study units or portion of the 
population from a defined study population to represent the total population and the 
findings from the sample may represent the characteristics of the rest of the group. 
 
In this study sampling was done from the ART unit at the selected hospital from 26 May 
till 12th June, 2015. The sample population consisted of women enrolled into HIV care 
and treatment, which are on ART or ART naïve and consented to participate in the 
study and were 18 years and above. Polit and Beck (2006:511; 2008:352) mention that 
  
27 
the target population is the entire population in which the researcher is interested and to 
which she/he would like to generalize the study results (Burns & Grove 2005:341-342; 
Polit & Beck 2006:511; 2008:352). A sample of those who were on HIV care and 
treatment were reviewed from the appointment register and daily register for patients. 
 
3.5 DATA COLLECTION 
 
According to Burns and Grove (2005:4) and Polit and Beck (2006:498; 2008:414), data 
collection is the gathering of information to address a research problem. It is the 
precise, systematic gathering of information relevant to study purpose or the specific 
objectives or questions of the research. 
 
3.5.1 Data collection instrument 
 
A self-structured questionnaire was used to collect data. The questionnaires were in 
English language and then translated into SiSwati. The questionnaire had closed-ended 
and few open-ended questions. The questionnaire had three sections (demographics, 
screening uptake and knowledge/awareness on cervical cancer). 
 
3.5.2 Ensuring collection of quality data 
 
The researcher collected the data herself. The completed questionnaires were double 
checked by the researcher to ensure that all the data were collected. The data tool was 
free from any bias. 
 
3.5.3 Pretesting the instruments 
 
Polit and Beck (2006:296) define a pre-test as a small scale study to establish whether 
the instrument is useful in generating the required information. In this study, the data 
collection tool was pretested on 10 respondents who were comparable to sample 
respondents. Modifications were done on the questionnaire based on the outcomes of 
the pre-test results. The adjustment was implemented to ensure validity and reliability of 
the research instrument. The 10 questionnaires for the pre-test were excluded from this 
study. 
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3.6 VALIDITY AND RELIABILITY 
 
Validity and reliability are the two most significant standards for evaluating quantitative 
instruments. Thus precision is expressed as validity and reliability. 
 
Internal validity 
 
Internal validity refers to the extent to which it is possible to make an inference that the 
independent variable is truly influencing the dependent variable and that the relationship 
between the two is not the fake effect of a confounding factor (Polit & Beck 2008:303). 
The three types of validity had to be considered in this study were face, content and 
construct validity. 
 
Face validity 
 
Face validity refers to the subjective judgement on whether the data collection tool 
shows that it is measuring what it is supposed to measure (Polit & Beck 2008:302). In 
this study, the researcher had a questionnaire that had logical links and were relevant to 
the study objectives and questions. The researcher translated the tool from English to 
the local language, SiSwati. To avoid the challenge that can be created due to technical 
words and misinterpretations, the tool was translated into SiSwati by a linguistic 
professional, and then translated back into English by an independent translator. This 
questionnaire was revised by the Swaziland Ethics Committee and the research 
supervisor. 
 
Construct validity 
 
Construct validity defines how well a test or experiment measures up to its claims. It is 
an inference of how well a certain tool measures a theoretical construct. It warrants that 
the abstract concepts are measured logically and the association between variables is 
identified with the tool based on theory and clear operational definitions (Burns & Grove 
2005:217). 
 
In this current study, the variables were operationalised to create common 
understanding between the researcher and readers. The questionnaire was constructed 
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based on the reviewed literature and the relevant variables to be measured to 
determine the degree to which it will collect the required information. Pre-testing the tool 
was also helpful. 
 
Content validity 
 
Polit and Beck (2006:328) indicate that content validity is a systematic assessment of 
the content of a tool to make certain that it effectively represents the entire content area. 
It is assessed on the basis of the extent to which items or questions represent the issue 
they are supposed to measure. In this study, the researcher verified content validity by 
asking research experts in tool development to evaluate it. The experts also validated 
the appropriateness, accuracy and representativeness of the instrument. Modification 
on the tool was done; literature review also added value to the design and validity of the 
tool. In this study, the researcher pre-tested the tool. 
 
External validity 
 
This is how accurate the study is in providing knowledge that can be applied outside the 
present sample and population (Polit & Beck 2008:301). In this study, the researcher 
had to ensure that the selected sample is representative of the population and that the 
findings can be more readily applied to a broader group. The researcher assumed that 
by statistically selecting the sample of 125 from HIV positive women attending this 
hospital, it will be a representative of other clinical settings. The study site was also 
carefully selected to be a representative of other hospitals. 
 
Reliability refers to the consistency  
 
Reliability refers to the consistency with which a measure can be relied on to give the 
same result if the aspect being measured has not changed. A research instrument can 
be unreliable if a slight ambiguity in the wording of questions is ambiguous. In this 
study, the researcher is the only person who collected the data and the information was 
constantly checked for completeness during data collection. 
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3.7 DATA ANALYSIS 
 
A database and entry screen were developed in Microsoft access 2013, of which the 
study dataset was mined and exported to SPSS version 22 for analysis. The objectives 
and questions of the study were used in developing a data analysis and tabulation plan 
to guide the analysis process. Descriptive analysis was accomplished by populating 
frequencies, tables and charts and cross tabulations for quantitative analysis. In 
addition, post coding of quantitative data was conducted to analyse open ended 
questions. Thereafter, description of data in meaningful terms to obtain answers to 
research questions was conducted. 
 
3.8 ETHICAL CONSIDERATIONS 
 
In this study, the researcher observed the ethical principles. 
 
3.8.1 Permission to conduct the study 
 
Since the study was conducted in a regional hospital, permission to conduct the study 
was sought from the regional health administrator’s office. Permission was also sought 
from the UNISA Ethical Committee and the Swaziland Ethics Committee. Annexure 3  
 
3.8.2 Confidentiality 
 
The questionnaire for data collection was anonymous; no name was written except 
unique identifiers. The questionnaire had numbers assigned and data were reported in 
aggregate form. In addition, the researcher did not mention the name of the site. The 
completed data collection tools were stored in a lockable cabinet and the researcher 
used a personal laptop that was locked at all times. 
 
3.9 SUMMARY 
 
The methodology was discussed in this chapter. Chapter 4 will be discussed next and it 
contains the study findings, and discussions surrounding it. The conclusions, limitations 
and recommendations will be discussed in Chapter 5. 
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CHAPTER 4 
 
DATA ANALYSIS AND INTERPRETATION OF RESULTS 
4.1 INTRODUCTION 
 
In Chapter 3, the research methodological processes that were used in the current 
study were discussed. This was the research design, study site, target population, 
sampling methods, data collection techniques, validity and reliability of the research 
instrument, pretesting of the research instrument, ethical considerations and data 
analysis procedures. In addition, the ethical concepts of research were explained. In the 
current chapter, the findings from the data are presented and discussed along with 
statistical analysis. 
 
4.2 STATEMENT OF THE RESEARCH PROBLEM 
 
Cervical cancer is one of the non-communicable diseases affecting women. It is the 
second most common cancer among women worldwide. Prevention of cervical cancer 
relies on the detection and treatment of squamous intraepithelial lesion, which is a 
premalignant stage. 
 
There is also a low uptake of women screening for cancer of the cervix; and women in 
Swaziland also come late for the screening. There is paucity of data in relation to high 
HIV infection and high rate of cancer of the cervix, and maybe due to the fact that 
Swaziland does not have a comprehensive service on management of cancer of the 
cervix. To the researcher’s knowledge there has not been a study conducted to assess 
the level of awareness knowledge about cervical cancer screening among HIV positive 
women in Swaziland. 
 
4.2.1 Research objectives 
 
The specific objectives were as follows: 
 
 To identify and characterize socio-economic demographic factors associated with 
accessing cervical cancer screening services by women in Swaziland. 
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 To explore the factors affecting the uptake of cervical screening for cancer of 
women in Swaziland. 
 Assess knowledge of cervical cancer and awareness of screening 
regimes/routines among HIV positive women in Swaziland. 
 
4.3 DATA ANALYSIS 
 
Data were collected at the selected hospital by the researcher using a questionnaire. 
The sample size of the study was 125. Both database and entry screen were developed 
in Microsoft Access 2013, of which the study dataset was mined and exported to SPSS 
version 22 for analysis. The objectives and questions of the study were used in 
developing a data analysis and tabulation plan to guide the analysis process. 
Descriptive analysis was accomplished by populating frequencies, tables and charts 
and cross tabulations for quantitative analysis. Post coding of quantitative data was 
conducted to analyse open-ended questions. Thereafter, description of data in 
meaningful terms to obtain answers to research questions was conducted. 
 
4.4 SECTION A: DEMOGRAPHIC CHARACTERISTICS 
 
The sample consisted of 123 respondents instead of the 125 that was intended. Two 
respondents withdrew from the study. The 123 were HIV positive women who were 
either on ART or PREART as described in the Swaziland Cervical Cancer Guidelines of 
(2013:6). The sample consisted of women aged 18 and upwards because the age 
group is one of the cervical cancer risk factors (exposure to sexual activity <20 years of 
age). The demographic information includes age, race, marital status, educational level, 
residence, employment status, marital status and religion. 
 
4.4.1 Age distribution  
 
In this study, women aged from 18-49 years of age were enrolled. The mean age for the 
participants was 35 years and of the 123 women who participated in the study most of 
the women were in the age-group 26-33 and 34-41 which resulted 40 participants in 
each age-group 
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            Figure 4.1: Number of women who participated in the study  
                                              per age group (n=123) 
 
4.4.2 Race 
 
Regarding race, all the women that participated in the study were black due to the fact 
that the population in this area is black. 
 
4.4.3 Marital status 
 
The knowledge of marital status is crucial because studies have shown that it is an 
important determinant of health care utilisation. In this study, 45% of the women were 
married while 41% were single. 
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Figure 4.2: Respondents’ marital status (n=113) 
 
4.4.4 Level of education 
 
Education is one of the most critical variables in epidemiological reviews of health 
service utilisation. There is a positive relationship between levels of education and 
health service use. The lack of formal schooling and illiteracy has been usually 
associated with high risk and low health seeking behaviour. The general level of 
education in a country becomes a marker. About 83.8 % of participants had some form 
of education while 45% had up to the level of secondary education. 
 
 
Figure 4.3: Respondents by level of education (n=123) 
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4.4.5 Area of residence 
 
Regarding residence, participants resided in peri-urban, rural and urban areas. Majority 
of respondents came from the rural areas. Most of the participants (75.6%) resided in 
the rural areas. 
 
 
Figure 4.4: Respondents’ area of residence (n=123) 
 
4.4.6 Employment status 
 
The proportion of respondents that reported to be unemployed was 60.0% while 23.0% 
were employed full time. 
 
 
Figure 4.5: Employment status for the women (n=123)  
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4.4.7 Mean income per month 
 
 
                                Figure 4.6: Mean income per month (n=123) 
 
4.4.8 Religion. 
 
                      Figure 4.7 : Religion (n=123) 
 
In addition, the researcher wanted to know the religious beliefs of the respondents, of 
which n=120(97%) were Christians and n=3 were non-Christians (2.4%). 
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4.4.8 Sexual debut 
  
                              Figure 4.8 Sexual debut (n=123) 
 
With regards to sexual debut, this figure is showing that the majority (81.3%) of the 
respondents had sexual debut between 15-19 years whilst 19.7% had it at 20-24 years. 
One of the risk factors for cervical cancer is early sexual debut because women are 
repeatedly infected with the human papilloma virus. 
 
4.4.9 Women by number of sexual partners 
 
 
Figure 4.9: Proportion of women by number of sexual partners (n=123) 
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4.5 SECTION B: SCREENING UPTAKE 
 
4.5.1 Annual cervical cancer screening and turnaround time for pap smear 
results 
 
The current research assessed cervical cancer screening among HIV positive women. 
Only 23% of the participants actually screened for cervical cancer annually. 
 
77.0%
23.0%
No
Yes
 
Figure 4.10: Annual cervical cancer screening by participants                   
(n=123) 
 
Regarding turnaround time, most participants got their results after a long time. Of those 
who did PAP smear 29.0% of them did not receive results at all and equal number 29% 
received results at 8 months. 
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                   Figure 4.11: Pap smear turnaround time for results (n=123) 
 
4.5.2 Cervical cancer screening tests 
 
Figure 4.11 shows that 12% of those who screened for cervical cancer were done VIA. 
 
77.0%
6.0%
2.0%
2.0%
1.0%
12.0%
Never
Cytology screening
Cytology screening - pelvic
examination
Cytology screening - VIA
Pelvic examination
VIA
 
Figure 4.12: Cervical cancer screening tests used by the women (n=123) 
 
4.5.3 Health education in the ART clinic on cervical cancer screening 
(p=0.018 
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4.5. 4 Health education in ART clinic (n=123) 
 
 
              Figure 4.13: Health education in ART clinic (n=123) 
 
Of the clients who received no health education at the ART clinic, only 19% received 
cervical cancer screening and from those participants who received health education at 
the ART clinic 44% did screen for cervical cancer. 
 
4.5.5 IEC material at ART clinic 
 
The researcher wanted to know whether participants were able to get IEC material on 
cervical cancer screening, only 122 (1%) received IEC material. 
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                            Figure 4.14: Availability of IEC material in ART clinics (n=123) 
 
4.5. 6 Availability/accessibility of cervical cancer screening at the ART clinic 
 
The researcher wanted to know whether cervical cancer screening was accessible 
/available at the ART clinic. Only 4% of the respondents reported availability. 
 
 
Figure 4.15: Cervical cancer screening availability at ART 
Clinic by participants (n=123) 
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4.5.7 Planned cervical cancer screening programme in the ART clinic  
 
In this current study, the researcher wanted to assess whether cervical cancer 
screening is fully integrated in the ART clinic. Only 1 of the participants reported that 
services were well planned. 
 
 
                          Figure 4.16: Well-planned cervical cancer programme in the ART  
                                                unit (n=123) 
 
4.6 AWARENESS (KNOWLEDGE) ON CERVICAL CANCER 
 
4.6.1 Human Papilloma Virus (HPV) as a cause for cervical cancer 
 
Knowledge of HPV as a cause for cervical cancer.   
According to figure 4.16 only 3 (2.5%) knew that HPV causes cervical cancer. Majority 
did not know that it causes cervical cancer. 
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                         Figure 4.17 Knowledge on human papilloma virus (n=123) 
 
4.6. 2 Risk factors for cervical cancer 
 
Regarding cervical cancer risk factors, 75% of participants knew the risk factors for 
cervical cancer. Only 25% did not know the risk factors. 
 
25.0%
75.0%
No
Yes
 
                        Figure 4.18: Knowledge on cervical cancer risk factors by  
                                                 participants (n=123) 
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4.6.3 Cervical cancer screening frequency for HIV positive women 
 
The researcher wanted to know whether participants know how often an HIV positive 
woman should screen for HIV. The results showed that 10% said that it should be done 
at 6 months’ interval, 34% said once annually and 56% did not know at all. 
 
 
Figure 4.19: Cervical cancer screening frequency by participants (n=113) 
 
4.6.4 Risk perception to cervical cancer  
 
Of the women who participated in the study, 86% of those who were employed full time 
perceived cervical cancer to be a risk factor for HIV positive women. About 62% of the 
participants perceived themselves to be at risk of cervical cancer by virtue of being HIV 
positive. 
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Figure 4.21 Perception of risk factors by women (n=123) 
 
4.6.5 Perception of cervical cancer as a serious condition for HIV positive 
women 
 
With regards to cervical cancer as a serious condition for HIV positive women, 85 (69%) 
of the women perceived cervical cancer to be a serious condition for HIV positive 
women. Only 31% did not perceive it to be a serious condition. 
 
 
Figure 4.22: Cervical cancer perception as a serious condition (n=123) 
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4.9.3 Main source of cervical cancer information 
 
The researcher wanted to assess how participants got general information on cervical 
cancer screening programmes. 
 
Figure 4.21: Main source of cervical cancer information (n=123) 
 
Figure 4.21 shows that most of the participants got information from the radio (62/50%). 
Only 22 %( 185) received information from nurses. 
 
4.9.4 SUMMARY 
 This chapter presented and discussed the data analysis and the findings according to 
each variable from the questionnaire. The socio-economic demographic factors 
associated with accessing cervical cancer screening services by women in Swaziland 
have been described. 
 
Factors affecting the uptake of cervical screening for cancer of women in Swaziland 
were described and finally the level of awareness was discussed. The results have 
shown that health facilities are not yet providing quality services to ensure that women 
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are screened on cervical cancer. Fewer women are knowledgeable about cervical 
cancer as a condition and its risk factors. Chapter 5 will discuss the conclusions, 
limitations and recommendations of this study. 
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CHAPTER 5 
 
CONCLUSIONS, LIMITATIONS AND RECOMMENDATIONS 
 
5.1 INTRODUCTION 
 
Chapter 4 presented the results of this study. In this chapter, findings and 
recommendations will be suggested. Since the study has three objectives, the 
discussion will be in three sections that are per objective. The objectives are socio-
economic demographic factors associated with accessing cervical cancer screening 
services by women, factors affecting cervical cancer screening and assessment of 
knowledge of cervical cancer and awareness of screening regimes and routines among 
HIV positive women.  
 
5.2 SECTION A: SOCIO-DEMOGRAPHIC PARAMETERS 
 
This section summarizes the findings from Chapter 4 according to the socio-
demographic characteristics, namely; age, level of education, employment status, 
marital status and area of residence. Conclusions and recommendations will be set 
forth based on the findings. 
 
The study sample was N=123 women from the age 18 upwards. This sample was 
statistically calculated. So, it is enough for the study. The respondents were HIV positive 
women who were either on ART or PREART. As described in the Swaziland Cervical 
Cancer Guidelines (2013:6). The sample consisted of women aged 18 and upwards. 
This is because of one of the cervical cancer risk factors (exposure to sexual activity 
<20 years of age). 
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5.2.1 Age 
 
The sample comprised mainly of women aged 25-34. These are the middle-aged 
women. This age group was relevant because this is the group that is usually affected 
by cervical cancer (Swaziland cervical cancer Guidelines: 21) 
 
The study findings show that only 38% of the respondents aged 15-24 had a higher 
uptake of cervical cancer screening. This means that younger women find it necessary 
to screen for cervical cancer compared to older women. 
 
Conclusion  
 
It can be concluded that among the age groups, younger women are likely to access 
cervical cancer screening services than older women and this can be due to 
assertiveness of younger women. 
 
Recommendation 
 
o The health care workers need to sensitize all women about cervical cancer 
screening as part of routine care at all levels. All other age groups also need 
information on cervical cancer screening. 
o Health care workers need to be proactive when dealing with HIV positive in the 
younger age group. 
 
5.2.2 Marital status 
 
In this study, marriage did not have an influence on cervical cancer screening. Although 
there were more of the married women who were tested for cervical cancer, the 
difference was too small. 
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Conclusion 
 
This means that married women are also not aware that marriage can contribute to the 
incidence of cervical cancer, due to the fact that the papilloma virus can also be 
transmitted sexually leading to women being vulnerable to get cervical cancer. 
 
Recommendation 
 
It is known for a fact that male involvement in health care delivery is very important for 
improvement of family health seeking behaviour. Men should also be educated on 
cervical cancer prevention. 
 
5.2.3 Educational status 
 
Most participants had some form of education; only 18 participants did not have 
education at all. Of the respondents n=47 had secondary education and n= 32 had high 
school education. 
 
Conclusion 
 
Generally uneducated women tend to pay fewer visits to hospital, but in this case these 
women were all in care and they visit the facility on appointment, this unveils the fact 
that cervical cancer screening is not yet fully implemented by the health care workers. 
 
Recommendations 
 
The Swaziland national AIDS program should make cervical cancer screening a 
standard of care for all HIV positive women and improve the health education to inform 
the communities at grass roots level. 
 
5.2.4 Area of residence 
 
Most women who participated in the study were from the rural areas (75.6) % whilst 
10.6% resided in the urban area. 
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The women who utilised the services of cervical cancer screening were mostly from 
urban areas (46.2%). 
 
Conclusion 
 
Screening and early treatment for cervical cancer is feasible and it can be integrated 
into HIV care where reproductive health services are also in place. This can produce a 
high yield because the HIV positive women occasionally visit the clinic for follow up. 
 
Recommendation 
 
A one stop service at the ART clinic would allow women whether from the rural setting 
or urban to get an opportunity to be screened for cervical cancer. 
 
5.2.5 Employment status 
 
A bigger proportion of the participants were not employed. This could not prevent the 
women from accessing cervical cancer screening because it is free. However, this could 
affect women who live in the rural areas, since the service is not provided in primary 
health clinics. The rate of employment was very low, n=74 were unemployed. Only 28 
were employed full time and n=18 were employed part time. This could be due to the 
fact that the data were collected during working days. 
 
Conclusion 
 
The high unemployment rate is quite bad and it reflects that as a country we are not 
doing well in the SDGs, especially number 8. of achieving permanent and decent work 
for all including women. This is a barrier in health care services access, especially 
cervical cancer because women need transport fees to go to the health facilities. 
 
Recommendations 
 
The Swaziland MOH, should decentralize cervical cancer screening services to the rural 
clinics, so that women can access them and clients waiting time reduced, since the 
clients are sometimes in a hurry to catch transport back home. 
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Rural health motivators need to be trained on cervical cancer so that they can give 
information in the communities. Community dialogues can also be done as a strategy 
for sensitizing and demand creation. 
 
5.2.6 Income 
 
The study findings revealed that the most of the respondents were employed full time, 
few were not employed. The mean amount received per month was 1400 for 
participants who reached university. Those who were employed full time received 2646. 
 
Conclusion 
 
Basically, the participants were able to attend to hospital and whether they screen for 
cervical cancer or not was not related to money because, services are free. 
 
Recommendation 
 
Respondents who do not have a source of income must be referred to the community 
for income generating projects. 
 
5.2.7 Religion 
 
The study findings showed that majority of the respondents were Christian’s p=120, 
fewer were not Christians. Some religious practices influence health seeking behaviour. 
In this study respondents were not affected by religion in order to screen. 
 
Conclusion 
Since majority of respondents were Christians, nothing much needs to be adjusted. 
 
Recommendation 
 
Health care workers need to be proactive and pick early any unfavourable religious 
beliefs. 
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5.2.8 Sexual debut  
 
Swaziland has the highest HIV prevalence in the world and the risk of cervical cancer is 
also high because women have early sexual debut as indicated in this study. In this 
study, 80% of the participants had their sexual debut before 20 years. 
 
Conclusion 
 
This is a revelation that women start their sexual activity very early. This is a cause for 
concern; early sexual debut exposes women to early HIV and HPV infection. So, 
vaccination of girls early in life is very important in primary prevention. This is so 
because the vaccines do not treat pre-existing HPV. 
 
Recommendation 
 
The Swaziland Ministry of Health needs to focus in prevention programmes. The HPV 
vaccine needs to be introduced at early ages of girls. This can be incorporated in the 
clinics and the school health programme. 
 
5.3 SECTION B: FACTORS AFFECTING CERVICAL CANCER SCREENING 
 
5.3.1 Annual Pap smear and turnaround time for results 
 
In this study only 23%of the respondents were found to have screened for cervical 
cancer using PAP smear. The turnaround time for results is very critical in that it helps 
the clinicians to act promptly. In this study 29% of the results never came back to the 
facility, those that came back came in the interval of 1-3 months.  
 
The main barriers of cervical cancer screening in developing countries are lack of 
awareness of cervical cancer screening. Women are not willing to screen for cervical 
cancer and lack of political commitment leads to poor cervical cancer screening by 
women (Moodley 2009:11). 
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Conclusion 
 
Screening clients and not giving them the results is bad practice and it leads to client’s 
dissatisfaction to quality service delivery. 
 
Recommendations 
 
Health facilities need to have a system to ensure that clients receive their results. There 
should be collaborative quality improvement projects implemented with specific 
indicators. 
 
5.3.2 Cervical cancer screening tests done 
 
Out of the 23% of respondents who did a cervical cancer screening test, 12% did VIA, 
6% cytology and 3% pelvic examination. This is a low percentage considering the fact 
that the women are all HIV positive. 
 
Conclusion 
 
This is a very low % that screened for cervical cancer. V IA is cheaper and easy to do; it 
is very unfortunate that only 12% was tested using that method. 
 
Recommendation 
 
The MOH SRHU department need to assess and accredit health facilities to do cervical 
cancer screening using simpler methods like the VIA. 
 
5.3.3 Health education in the ART clinic on cervical cancer screening 
 
With regards to health education in the ART unit, of those who did not receive health 
education, 19% screened for cervical cancer and of the 56% who received health 
education, 44% were screened for cervical cancer.  
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Conclusion 
 
Information links to positive behaviour  
 
Recommendation  
 
 Health education on cervical cancer screening services scale up needs to be 
strengthened. Cervical cancer screening services needs to be improved in order to 
reduce morbidity and mortality due to cervical cancer. Health care providers should be 
trained on cervical cancer screening so that they can educate clients. 
 
5.3.4 IEC material on cervical cancer at the ART clinic 
 
All respondents reported that there was no IEC material at the clinic except for Only 
1(0.8%) respondent who claimed to have received IEC material at the clinic. 
 
Conclusion 
 
IEC material on cervical cancer is very critical, because women who can read can get 
information whilst they are waiting to be seen, they can also further read when they are 
at home and this complements what the health care worker said during an education 
session. 
 
Recommendation 
 
Develop various Information, Education and Communication (IEC) materials regarding 
cervical cancer.  
 
5.3.5 Availability/Access to cervical cancer screening at the ART clinic 
 
Only 4% of the respondents reported that a health care worker offered to screen them 
for cervical cancer. This is an act of omission of a service to a woman who is eligible. 
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Conclusion 
 
Offering cervical cancer screening to a woman is important in order to reduce morbidity 
and mortality to the women. It enables the health care workers to identify high risk 
groups and individuals that need special monitoring and care. 
 
Recommendations 
 
o Comprehensive health education to HIV positive women is needed, emphasizing 
early screening and treatment. 
 
o Male involvement should be promoted because it will assist families in taking 
informed decisions. 
 
5.3.6 Planned cervical cancer screening program at the ART clinic 
 
With regards to whether cervical cancer screening program was well planned at the 
ART clinic or not, 99.8% respondents stated that cervical cancer was not well planned. 
This is what they had to say “It is done in another department, it’s strenuous for me to 
go and que there” It is done in another unit”. “It’s not convenient for me to visit another 
department.” 
 
Conclusion 
 
Service integration is very critical for every client; it reduces clients waiting time, 
promotes privacy and ensures that there are no missed opportunities. 
 
Recommendation 
 
Cervical cancer screening should be integrated within all ART clinics. 
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5.4 SECTION C: AWARENESS (KNOWLEDEGE) ON CERVICAL CANCER 
 
5.4.1 Is human papilloma virus known to be a cause for cervical cancer? 
 
89% of the respondents reported not to even know what HPV is, 2.4 % reported that 
yes HPV causes cervical cancer and 8.9% reported that HPV does not cause cervical 
cancer. 
 
Conclusion 
 
There is need to empower women to understand their health care needs and basic 
screening procedures so as to increase uptake of this health service. 
 
Recommendation 
 
Health education on cervical cancer has to be packed in such a way that women know 
what HPV is and how it contributes to cervical cancer. 
 
5.4.2 Cervical cancer risk factors 
 
Respondents were asked to name risk factors for cervical cancer ranging from HIV 
infection, multiple sexual partners, low cd4 and use of hormonal contraceptives. A 
bigger percentage (75%) perceived themselves to be at risk of getting cervical cancer 
due to the fact that they are HIV positive. While a very low percentage (25%) felt that 
they were not at risk of getting cervical cancer regardless of their positive HIV status. 
Some women believe that anyone can get cervical cancer; they believed that a woman 
should seek medical help once signs and symptoms appear. According to Moodley 
(2009:12), women in developing countries usually come to a facility when there are 
already signs and symptoms and that is when the disease is at an advanced stage. 
 
The cervical cancer screening rate is lower than the risk of getting it. The Swaziland 
National Cervical Cancer Guidelines (2013:33) stipulates that HIV positive women are 
more at risk of cervical cancer. Literature also states that disease progression of pre-
cancer lesions to invasive cancer is very fast (Health Systems Trust 2009:18).  
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Conclusion 
 
Despite knowledge of being at risk to have cervical cancer, women are not screening for 
cervical cancer. 
 
Recommendation 
 
HIV positive women should be screened biannually on cervical cancer, appointment 
maybe combined with other services like viral load. 
 
5.4.3 Cervical cancer screening frequency 
 
In this study only 10% of the respondents reported that it is done in 6 months’ intervals, 
56% had no idea about the subject and 34% reported that it is done annually HIV 
positive women should be screened for cervical cancer twice a year (Swaziland cervical 
cancer guidelines, 201321).  
 
Conclusion 
 
This is a course for concern; women do not know the frequency of screening for cervical 
cancer. Lack of knowledge is the factor behind this. This manifest ignorance from the 
health care workers. 
 
Recommendation 
 
Health care workers need to be trained comprehensively on cervical cancer. Guidelines 
should be distributed in the health facilities. 
 
5.4.4 Perception of cervical cancer as a serious condition for HIV positive women 
 
Respondents in this study were asked whether they perceived cervical cancer to be a 
serious condition to HIV positive women and they were asked why? . N=85 responded 
yes they perceived cervical cancer to be a serious condition and their reasons were that 
the lowered immunity contributed in one getting cervical cancer. Only n=38 responded 
No. 
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Conclusion 
 
Women need to know the relationship between HIV and cervical cancer, so that they 
take informed decisions. 
 
Recommendation 
 
At enrolment for HIV care, women should be screened for HIV, health care workers 
need to ensure that they comprehend; this should be a standard of care. 
 
5.4.5. Main source for cervical cancer information 
 
In this study it was encouraging to note that N=62 (50%) of the respondents got 
information about cervical cancer from the radio. However, it was discouraging to learn 
that only n=22(18%) got information on nurses. One would expect that these women 
would get information from nurses due to the fact that they are on chronic care. Lack of 
recommendations from health care workers contributes to low screening uptake. 
 
Conclusion 
 
Without proper information on cervical cancer, women are not able to be assertive in 
initiating cervical cancer screening for them. Some women thought that the cervix is the 
bladder. 
 
Recommendation 
 
There is a need to scale up cervical cancer screening in order to reduce the incidence 
and mortality of cervical cancer. 
 
5.5 LIMITATIONS OF THE STUDY 
 
Despite the fact that this study has produced significant findings, some limitations are 
outlined below:  
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 This study was performed in one hospital; so, the results may not be generalized 
for the general population and other countries. 
 
5.6 RECOMMENDATIONS REGARDING FURTHER STUDIES 
 
 Data collection should be done in several health facilities in the region to yield 
more relevant data. 
 Qualitative research should be conducted to get in-depth information. 
 Studies targeting health care workers about cervical cancer screening should be 
conducted as they play a major role in promoting health services. 
 
5.7 FINAL CONCLUDING REMARKS 
 
Cancer of the cervix is preventable. Cervical cancer screening and early treatment is 
vital in every country. This study showed a low level of awareness which resulted in 
poor uptake. To reduce the incidence of cervical cancer these should be addressed. 
The general population need to know about cervical cancer, service providers should 
make it a routine to screen patients especially those who are already on chronic care 
like HIV, these clients miss opportunities. Cytology has a high sensitivity as a screening 
test but VIA is cheaper and it has proven to have similar sensitivity but lower specificity 
and positive predictive value when evaluated in clinical research settings (Deodhar et 
al., 2012). 
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ANNEXURE 4: Questionnaire 
 
My name is Thembisile Chili I am doing a Master’s Degree in Public Health the 
Department of Health studies at the University of South Africa. I am doing a research on 
Knowledge of cervical cancer and awareness of screening regimens/routines among 
HIV positive women in Swaziland. I therefore request your participation through an 
interview guide in this research study. The interview will take between twenty to thirty 
minutes. The information gathered will be private and confidential that is, it will be used 
for academic purposes only. 
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Questionnaire 
Instructions: tick in the box for what is relevant 
Section A: Demographic Questionnaire 
1. Age in years……………………………………. 
2. Race. 
a) Black 
b) White 
c) Indian                                                                           
d) Chinese 
e) Other; specify………………………………  
 
3.  Marital status. 
a) Married 
b) Single 
c) Divorced 
d) Widow 
e) Separated 
f) Cohabiting                                                                                         
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4.  Level of education. 
a) Did not attend 
b) Primary 
c) Secondary 
d)  High school 
e) University /college  
                                                                             
5. Area of Residence. 
a) Rural 
b) Peri-urban 
c) Urban 
6. Employment status 
a) Unemployed 
b) Part time 
c) Full time 
d) Other 
specify…………………………………………………………………………… 
7.  Income per month in SZL………………………………………. 
8.  Religion. 
a) Christian-specify 
denomination……………………………………………………….. 
b) Moslem 
c) Traditional 
d) Other, specify…………………………………………………………………… 
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9.  Do you smoke cigarettes? 
a) Yes 
b) No 
c) If Yes: 
i) When did you start smoking……………………………….. 
ii) Number of cigarettes per day………………………………. 
10. At what age did you start having sexual intercourse?……………………… 
11. How many sexual partners do you have?………………………………………… 
12. How many children do you have?…………………………………………………… 
13. Have you ever been diagnosed as having external genital warts? 
a) Yes  
b) No 
14. Have you ever been treated for any Sexually Transmitted Infections? 
a) Yes  
b) No 
15.  When were you diagnosed HIV Positive…………………………………………. 
 
Section B: Screening Uptake Questionnaire 
 
16 Do you get an annual pap smear? 
a) Yes.  
b) No. 
c) How long does it take for the results of the screening tests……………………. 
…………………………………………………………………………………… 
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17.  Have you ever undergone any of the following cervical screening tests? 
a) Pelvic examination                                                                                           
b) Cytology screening 
c) Colposcopy 
d) Visual Inspection with Acetic Acid (VIA)  
e) HPV test 
 
If yes to one or more of the above:  
Indicate…… how often?.......................................................... 
If No to any of the above what are the reasons for the failure to receive 
screening? 
a) Do not know about the test. 
b) It is not available to me. 
c) It is not accessible to me. 
d) It is expensive to me.  
e) Fear of positive results. 
f) Fear of the pain of the procedures. 
g) Not comfortable being examined by a male 
h) Other reasons, specify…………………………………………………………. 
…………………………………………………………………………………. 
…………………………………………………………………………………. 
18.  Do you get health education in the ART Clinic on cervical cancer screening? 
a) Yes 
b) No 
Comment: ………………………………………………………………………………… 
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19.  Do the health care providers in the ART Clinic provide you with a cervical cancer 
screening IEC material? 
a) Yes  
b) No  
Comment: ………………………………………………………………………………… 
 
20. Are the cervical screening services readily available or accessible in the ART 
clinic? 
a) Yes 
b) No 
Comment: ………………………………………………………………………………… 
 
21.  Do you consider the cervical cancer screening program in the ART clinic well 
planned? 
a) Yes  
b) No  
Comment: ………………………………………………………………………………… 
 
 
Section C: Awareness (knowledge) on Cervical Cancer 
22.  Does Human Papilloma Virus (HPV) causes cervical cancer? 
a) Yes  
b) No 
c) Do not know 
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23.  The following are risk factors for cervical cancer? 
a) HIV infection                                                                                 
b) Immunosuppression (CD4+ cell count of less than 200)  
c) High number of sexual partners 
d) Cigarette smoking 
e) Use of hormonal contraceptives 
Other:………………………………………….. 
24.  How often should an HIV positive woman go for cervical cancer screening? 
a) Once annually 
b) At 6-month interval following two initial normal Pap smears, then a cytologic 
examination annually 
c) Do not know 
 
25.  Do you perceive yourself to be at a higher risk of having cervical cancer because 
you are HIV positive? 
a) Yes 
b) No 
26. Do you perceive cervical cancer to be a serious condition to HIV positive 
women? 
a) Yes  
b) No  
c) Explain your answer……………………………………………………………… 
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27.  How did you know about cervical cancer screening programs? 
 
a) Gynecologist 
b) General practitioner (Doctor) 
c) Nurse 
d) Counselor 
e) Radio 
f) Magazines/newspapers 
g) Never heard 
h) Others specify……………………………………………………………. 
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ANNEXURE 5: Letter from the editor 
 
